CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $1.56B, above the global median of $1.14B
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.16BGBP1.56B · vs all stocks (USD)
Trailing P/E
44.50xRevenue (TTM)
706.90MGBP946.91M · vs all stocks (USD)
Profit Margin
5.15%Beta
1.96xvs all stocks
52-Week Change
187.10%vs all stocks
Market Capitalization
1.16BGBP1.56B · vs all stocks (USD)
Enterprise Value
936.73MGBP1.25B · vs all stocks (USD)
Trailing P/E
44.50xForward P/E
14.11xPrice to Sales (TTM)
1.65xPrice to Book (MRQ)
9.29xEnterprise to Revenue
1.32xEnterprise to EBITDA
6.42xProfit Margin
5.15%Operating Margin
15.20%Return on Assets (TTM)
5.83%Return on Equity (TTM)
30.28%Revenue (TTM)
706.90MGBP946.91M · vs all stocks (USD)
Revenue per Share (TTM)
4.93GBPUpdated Oct 25, 2026Quarterly Revenue Growth
12.30%Gross Profit (TTM)
343.90MGBP460.66M · vs all stocks (USD)
EBITDA (TTM)
143.30MGBP191.95M · vs all stocks (USD)
Net Income (TTM)
27.60MGBP36.97M · vs all stocks (USD)
Operating Cash Flow (TTM)
179.20MGBP240.04M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
328.09MGBP439.48M · vs all stocks (USD)
5-Year Average Dividend Yield
6.47%vs all stocks
Payout Ratio
0.00%Revenue
660.00MGBPFY2026 · Jan 31, 2026Cost of Goods Sold
341.10MGBPFY2026 · Jan 31, 2026Gross Profit
318.90MGBPFY2026 · Jan 31, 2026Operating Income
100.50MGBP134.62M · vs all stocks (USD)
Pre-tax Income
2.10MGBPFY2026 · Jan 31, 2026Income Tax Expense
-2.00MGBPFY2026 · Jan 31, 2026Net Income
3.60MGBPFY2026 · Jan 31, 2026EBIT
67.90MGBPFY2026 · Jan 31, 2026EBITDA (Income Statement)
143.30MGBPFY2026 · Jan 31, 2026Selling, General & Administrative
124.70MGBPFY2026 · Jan 31, 2026Other Operating Expenses
900.00KGBPFY2026 · Jan 31, 2026Non-operating Interest Income
6.10MGBPFY2026 · Jan 31, 2026Non-operating Interest Expense
65.80MGBPFY2026 · Jan 31, 2026EPS (Basic)
0.0250GBPFY2026 · Jan 31, 2026EPS (Diluted)
0.0240GBPFY2026 · Jan 31, 2026Basic Shares Outstanding
142.40MSharesFY2026 · Jan 31, 2026Diluted Shares Outstanding
142.40MSharesFY2026 · Jan 31, 2026Net Income from Continuing Operations
4.50MGBPFY2026 · Jan 31, 2026Preferred Stock Dividends
0.00GBPFY2026 · Jan 31, 2026Operating Cash Flow
103.80MGBPFY2026 · Jan 31, 2026Free Cash Flow
88.70MGBPFY2026 · Jan 31, 2026Cash & Cash Equivalents (End of Period)
256.70MGBPFY2026 · Jan 31, 2026Starting Profit (CF Statement)
4.50MGBPFY2026 · Jan 31, 2026Stock-based Compensation
3.90MGBPFY2026 · Jan 31, 2026Other Non-cash Items
60.20MGBPFY2026 · Jan 31, 2026Change in Other Assets/Liabilities
35.20MGBPFY2026 · Jan 31, 2026Capital Expenditures
-15.10MGBPFY2026 · Jan 31, 2026Net Acquisitions
-15.60MGBPFY2026 · Jan 31, 2026Purchase of Investments
0.00GBPFY2026 · Jan 31, 2026Sale of Investments
36.80MGBPFY2026 · Jan 31, 2026Net Investing Cash Flow
6.10MGBPFY2026 · Jan 31, 2026Long-term Debt Issuance
335.00MGBPFY2026 · Jan 31, 2026Long-term Debt Payments
-380.60MGBPFY2026 · Jan 31, 2026Net Financing Cash Flow
-45.60MGBPFY2026 · Jan 31, 2026Shares Outstanding
143.96MSharesUpdated Oct 25, 2026Float Shares
81.79MSharesUpdated Oct 25, 2026% Held by Insiders
36.74%vs all stocks
% Held by Institutions
25.86%vs all stocks
Total Cash (MRQ)
210.30MGBP281.70M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.47GBPUpdated Oct 25, 2026Total Debt (MRQ)
646.60MGBP866.13M · vs all stocks (USD)
Current Ratio (MRQ)
0.9120xBook Value per Share (MRQ)
0.8620GBPUpdated Oct 25, 2026Total Assets
1.28BGBP1.71B · vs all stocks (USD)
Total Current Assets
432.70MGBPFY2026 · Jan 31, 2026Total Liabilities
1.21BGBPFY2026 · Jan 31, 2026Total Non-current Assets
842.90MGBPFY2026 · Jan 31, 2026Total Non-current Liabilities
682.20MGBPFY2026 · Jan 31, 2026Total Current Liabilities
523.70MGBPFY2026 · Jan 31, 2026Cash
70.20MGBPFY2026 · Jan 31, 2026Cash Equivalents
186.80MGBPFY2026 · Jan 31, 2026Cash & Cash Equivalents
257.00MGBPFY2026 · Jan 31, 2026Other Short-term Investments
1.00MGBPFY2026 · Jan 31, 2026Accounts Receivable
98.40MGBPFY2026 · Jan 31, 2026Inventory
8.40MGBPFY2026 · Jan 31, 2026Accounts Payable
168.50MGBPFY2026 · Jan 31, 2026Short-term Debt
63.30MGBPFY2026 · Jan 31, 2026Long-term Debt
583.30MGBPFY2026 · Jan 31, 2026Common Stock (Book)
21.70MGBPFY2026 · Jan 31, 2026Retained Earnings
-604.70MGBPFY2026 · Jan 31, 2026Total Shareholders' Equity
69.70MGBP93.36M · vs all stocks (USD)
Treasury Stock
1.60MGBPFY2026 · Jan 31, 202652-Week Low
234.50GBXUpdated Oct 25, 202652-Week High
819.00GBXUpdated Oct 25, 202652-Week Change
187.10%vs all stocks
Beta
1.96xvs all stocks
50-Day MA
688.96GBXUpdated Oct 25, 2026200-Day MA
597.35GBXUpdated Oct 25, 2026Avg 10-Day Volume
248.11KSharesUpdated Oct 25, 2026Avg 30-Day Volume
515.19KSharesUpdated Oct 25, 2026Diluted EPS (TTM)
0.1800GBPUpdated Oct 25, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $1.56B, above the global median of $1.14BNotable
Market cap (USD): 1,559,975,234.362Global Median: 1,138,450,684.034
Revenue is $946.91M, above the global median of $562.3MNotable
Revenue (USD): 946,906,645.135Global Median: 562,304,852.367
Levered free cash flow is $439.48M, above the global median of $18.69MNotable
Levered free cash flow (USD): 439,479,751.926Global Median: 18,689,872.41
Companies that share the same coordination system — how they create, deliver, or capture value.
Alignment Healthcare, Inc.
Tier 1RiskFloat-Funded Risk AbsorptionFlowInterface
Odontoprev S.A.
Tier 1RiskFloat-Funded Risk AbsorptionFlowInterface
Qatar Insurance Company
Tier 1RiskFloat-Funded Risk AbsorptionRuleFlow
Korean Reinsurance Company
Tier 1RiskFloat-Funded Risk AbsorptionFlowProduction
Yunfeng Financial Group Limited
Tier 1RiskFloat-Funded Risk AbsorptionInterfaceFlow
Central Reinsurance Co., Ltd.
Tier 1RiskFloat-Funded Risk AbsorptionFlowProduction
China Reform Health Management Co., Ltd.
Tier 1RiskFloat-Funded Risk AbsorptionFlowInterface
Lancashire Holdings Limited
Tier 1RiskFloat-Funded Risk AbsorptionProductionFlow
IRB Brasil Resseguros S.A.
Tier 1RiskFloat-Funded Risk AbsorptionFlowSenseMaking
Clover Health Investments, Corp.
Tier 1RiskFloat-Funded Risk AbsorptionFlowInterface